Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy
about
sameAs
Psychological and pharmacological interventions for depression in patients with coronary artery diseaseInfluence of antidepressants on hemostasisThe vital link between chronic disease and depressive disorders.Depression and the Link with Cardiovascular DiseaseSelective serotonin reuptake inhibitors and cardiovascular events: A systematic reviewAntiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: a randomized, placebo-controlled, double-blind trialClinical impact of selective serotonin reuptake inhibitors therapy with bleeding risksPlatelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence?Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials.Coronary heart disease and depression: a review of recent mechanistic research.Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortalityIn-silico prediction of blood-secretory human proteins using a ranking algorithm.Symptoms of anxiety and depression and risk of acute myocardial infarction: the HUNT 2 study.The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes.Early life adversity and inflammation in African Americans and whites in the midlife in the United States survey.Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients.Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients.Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications.Chronic kidney disease care in the US safety net.A neuroendocrine mechanism of co-morbidity of depression-like behavior and myocardial injury in rats.Depression in vascular pathologies: the neurologist's point of view.Broken heart: depression in cardiovascular disease.Epidemiology and treatment of depression in patients with chronic medical illness.Psychobiology of depression/distress in congestive heart failureRisk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarctionEpidemiology, diagnosis, and management of depression in patients with CKD.Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or deathState of Consultation-Liaison Psychiatry in India: Current status and vision for futureGeneral population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.Responses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial.Treatment of anxiety and depressive disorders in patients with cardiovascular disease.Selective serotonin reuptake inhibitor use is associated with right ventricular structure and function: the MESA-right ventricle study.Pharmacologic treatment of depression in patients with myocardial infarctionNegative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, and future directions.Frequency of depression among patients with acute coronary syndrome, eastern region, saudi arabiaDepression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches.Antidepressants and the risk of abnormal bleeding during spinal surgery: a case–control study.Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.Sertraline for the treatment of depression in coronary artery disease and heart failure.Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues.
P2860
Q24234331-A69EF067-E540-4AA5-A21E-80A2955B8401Q24635625-47E4BAEB-F23A-4BD0-BD86-730B599BE1CCQ25255770-8F4663B9-8666-4F8A-B4D0-5FB3BF737669Q26752379-D4CD05D7-8107-4370-B4B2-76E24B4B745DQ28076706-1E22081E-3A6A-4299-9DB7-4FCA4976E8C9Q28195907-F4E0555E-1E6E-49F9-A960-9FFA699D0473Q28219114-916988A3-51A0-45C9-9689-6FFFD540D1FFQ31102771-BC47336B-F5CE-4934-9BF2-5B6CD50C933FQ33154720-4648E465-19DA-4014-AD1C-571D78D8DC59Q33266570-6BBC303C-BF51-40CD-AAC6-2143FB9CED6EQ33568470-C89C9BA0-F90D-4CD6-8E31-D17A4812D275Q33577512-903CE7EA-01A2-47BD-955C-60180D032F74Q33705509-F9EBDF5A-AF50-4A09-A4B5-069D09A49E23Q33868089-7FC6BD1E-CD9A-4D98-81D9-A20A94D9AB01Q34126561-5E94D22E-15C4-4AE4-9F1A-CF45A4C209A8Q34182611-9FC2AC46-2A18-4464-9FC7-A1CBEA6EB2D9Q34384552-03E59205-5CC2-4DA3-9BCD-9A8C2A87DC23Q34772883-B246B8AB-E0E6-4F67-9F2B-C72D82871C62Q34924764-C1B5A4CF-AB04-4996-890A-DAFF65C9C056Q35097384-48049B01-DB6A-4299-92F9-52DF6D77B13DQ35122942-2B3253C6-0B8F-4D58-8BAE-25B73102EEE2Q35236309-6C8665B5-BD87-4980-8A9B-0C9CA91679D1Q35237231-CB2329F0-D618-4A9B-9E3E-D582040BD2A6Q35293910-FF33F3AA-4092-4476-8A40-22F6F4125F9EQ35551130-4443312D-4F0B-4FC8-A27C-1F6B5DA5FD1BQ35553004-00569CC7-81DC-4080-B237-60C3BD1E74A8Q35553009-689E6E6B-02C9-435B-9A67-5AC1FDD1F9C3Q35564494-952B92AF-A7D1-441D-8936-2B48C74C54C8Q35583918-D30A75F4-4C04-46AD-A7BB-F2FC20F607FAQ35662050-4579D5CB-6A84-497F-8894-6887E564C3AFQ35746997-E683C715-78A0-4E7F-8DFA-884D7D3FC719Q35763631-6968C5B8-CB8D-4110-A203-7EDD76348E96Q36077310-19D34E06-1091-4B5A-9309-4355225E292EQ36115552-206E0E6B-2A06-4735-813C-859257644C65Q36134021-8610AA6F-E860-4D93-8420-866C229A1354Q36145832-A4FC8CFF-84B8-44B2-B873-8D9C94ADFF1EQ36295778-D67D8FE8-4BCA-48ED-9779-A47D5107E8E4Q36873138-DCE267F0-E143-45C0-82F4-D2C06B49FA69Q36895857-A126EC68-9EDC-4B3A-A633-F08A5B10F470Q36914846-4DBA0BE4-7BE8-430A-BA2E-0254BA060C18
P2860
Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Platelet/endothelial biomarker ...... al (SADHART) Platelet Substudy
@ast
Platelet/endothelial biomarker ...... al (SADHART) Platelet Substudy
@en
Platelet/endothelial biomarker ...... al (SADHART) Platelet Substudy
@nl
type
label
Platelet/endothelial biomarker ...... al (SADHART) Platelet Substudy
@ast
Platelet/endothelial biomarker ...... al (SADHART) Platelet Substudy
@en
Platelet/endothelial biomarker ...... al (SADHART) Platelet Substudy
@nl
prefLabel
Platelet/endothelial biomarker ...... al (SADHART) Platelet Substudy
@ast
Platelet/endothelial biomarker ...... al (SADHART) Platelet Substudy
@en
Platelet/endothelial biomarker ...... al (SADHART) Platelet Substudy
@nl
P2093
P921
P3181
P1433
P1476
Platelet/endothelial biomarker ...... al (SADHART) Platelet Substudy
@en
P2093
Alex I Malinin
Alexander H Glassman
Charles B Nemeroff
Dominique L Musselman
K Ranga R Krishnan
Louis T van Zyl
Michael Gaffney
Mitchell S Finkel
Victor L Serebruany
Wilma Harrison
P304
P3181
P356
10.1161/01.CIR.0000085163.21752.0A
P407
P577
2003-08-26T00:00:00Z